NCT03780517 2023-10-30Safety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered TumorsBoston PharmaceuticalsPhase 1 Completed117 enrolled
NCT00215605 2013-02-27Study of XL184 (Cabozantinib) in Adults With Advanced MalignanciesExelixisPhase 1 Completed85 enrolled